SELECT ISSUE

Indexată BDI | IDB Indexed
![]() | |
![]() |
|
![]() | |
![]() |
|
![]() |
|
![]() | |
![]() |
HIGHLIGHTS
Tema plagiatului este tot mai mult discutată în ultima vreme. Apariția unor programe performante de căutare și identificare a similitudinilor între texte [...]
Committe on Publication Ethics
A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.
Partners

FROM PATHOPHYSIOLOGY TO MOLECULAR DIAGNOSIS IN SUDDEN UNEXPECTED DEATH IN EPILEPSY
Carmen-Adella Sirbu, Dan Corneci, Florentina-Cristina Plesa, Octavian-Mihai Sirbu, Anca-Maria Sandu and Beatrice Ioan
ABSTRACT
Sudden unexpected death in epilepsy (SUDEP), an undesirable event with a relatively small prevalence, often unrecognized and underdiagnosed, is currently at the center of international medical and social events, with the specific purpose of awareness raising campaign. Although many general risk factors for SUDEP have been identified, the development of reliable patient-specific biomarkers is needed to provide more accurate risk prediction and personalized patient management strategies. The new different genes mutations described in animals and humans, make them valuable genomic biomarkers. In this paper the authors analyze aspects of SUDEP pathogenesis and diagnosis from the perspective of both the current molecular research and the new diagnostic criteria proposed by Nashef et al. in 2012. The authors conclude that in the genomic era we shall be able to optimize and individualize patient management, focusing in the same time on prevention.
Keywords: SUDEP, epilepsy, pathogenicity, genetic biomarkers, personalized medicine, prevention
Full text | PDF